+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
D Alpha Parahydroxy Phenylglycine & Derivatives Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
D Alpha Parahydroxy Phenylglycine & Derivatives Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

D Alpha Parahydroxy Phenylglycine & Derivatives Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081323
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The realm of specialty chemicals has witnessed a notable evolution with the ascent of D Alpha Parahydroxy Phenylglycine and its derivatives. As a key chiral building block, this compound underpins the synthesis of a broad spectrum of pharmaceuticals, including antibiotics, antihypertensive agents, and antidepressants. Its derivatives-ranging from ethyl ester hydrochloride to sodium salt-offer tailored reactivity profiles, enabling precise control in asymmetrical catalysis and peptide assembly. The growing complexity of active pharmaceutical ingredients has propelled demand for high-purity intermediates, while advances in synthetic pathways have driven efficiency gains. Simultaneously, increasing emphasis on stringent regulatory compliance and environmental stewardship has reshaped production paradigms, encouraging shifts toward greener, more cost-effective processes. Against this backdrop, stakeholders across chemical manufacturing, biotechnology, and contract research organizations are reassessing sourcing strategies, optimizing process selection, and forging strategic partnerships to secure reliable supply chains. This report lays the groundwork for understanding the forces steering this market, presenting an informed overview of current dynamics and revealing the strategic levers available to industry leaders seeking competitive advantage.

Transformative Shifts Redefining the Parahydroxy Phenylglycine Landscape

In recent years, multiple forces have converged to redefine the parahydroxy phenylglycine landscape. Technological breakthroughs in catalytic hydrogenation and esterification processes have reduced reaction times and enhanced yields, while the adoption of continuous manufacturing has bolstered scalability and quality control. Simultaneously, regulatory frameworks worldwide have tightened, prompting manufacturers to embrace greener chemistries and robust impurity profiling. The rise of precision medicine has further amplified demand for chiral intermediates, intensifying investments in asymmetric catalysis and direct synthesis routes. On the market side, supply chain disruptions have accelerated digital transformation efforts, with real-time analytics enabling proactive risk mitigation. Geographic shifts are also underway: production hubs in Asia-Pacific are expanding capacity, while Americas-based firms are diversifying feedstock sources to shield against volatility. This transformative milieu demands agile strategies, as companies must reconcile cost pressures with sustainability targets and navigate a tighter regulatory environment. By understanding these paradigm shifts, decision-makers can harness emerging opportunities and build resilient, future-ready operations.

Cumulative Impact of United States Tariffs in 2025 on Supply Dynamics

The implementation of elevated United States tariffs in 2025 has exerted cumulative effects on the parahydroxy phenylglycine value chain. Increased duty burdens have elevated landed costs for imported intermediates, compelling domestic manufacturers to reevaluate supplier portfolios and consider nearshore production alternatives. Pharmaceutical intermediaries reliant on antibiotic and antihypertensive synthesis have experienced margin compression, prompting tighter collaboration between procurement and R&D teams to identify cost-efficient raw material grades. Moreover, research and development functions engaged in clinical trials and laboratory experiments are reassessing budgets in light of higher reagent prices. As a result, some firms are accelerating technology transfers to local manufacturing sites, reducing exposure to import tariffs. Simultaneously, the heightened cost environment has spurred process innovation, with a renewed focus on direct synthesis pathways that minimize byproducts and lower purification requirements. This interplay between policy-driven cost pressures and operational agility underscores the importance of strategic supply chain planning and technology diversification in maintaining competitiveness.

Key Segmentation Insights Driving Market Differentiation

A nuanced examination of market segmentation reveals the breadth of demand drivers and process considerations at play. Across product types, conventional acid forms coexist with ethyl ester hydrochloride, hydrochloride, and sodium salt variants, each selected for its solubility profile and downstream reactivity. Application segments further clarify value streams: chemical synthesis activities encompass asymmetrical catalysis and peptide synthesis, while pharmaceutical intermediaries supply antibiotic, antidepressant, and antihypertensive drug manufacturing. In parallel, research and development workflows-ranging from clinical trial reagent preparation to intricate laboratory experimentation-sustain innovation pipelines. End-user industries illustrate adoption patterns: the chemical sector’s manufacturing companies and specialty chemical producers prioritize cost efficiency and scale; the healthcare arena’s biotechnology firms and contract research organizations demand rigorous purity standards; and the pharmaceutical domain’s drug manufacturers and R&D institutes require seamless regulatory compliance. Process segmentation highlights catalytic hydrogenation, direct synthesis, and diverse esterification methodologies, with acid-catalyzed and base-catalyzed options enabling tailored reaction kinetics. Purity tiers span low purity below 95 percent through high purity between 95 and 99 percent up to ultra-high purity at or above 99 percent, while product forms include crystalline solids, liquid solutions, and powdered intermediates. These segmentation insights equip stakeholders with a roadmap for prioritizing investment and aligning capabilities to market requirements.

Key Regional Insights Shaping Global Distribution Trends

Regional dynamics offer further clarity on market trajectories. In the Americas, manufacturers are advancing capacity expansions to offset tariff-driven cost pressures, with an emphasis on high-purity production and continuous flow technologies. Meanwhile, Europe, the Middle East, and Africa exhibit a dual focus: established chemical hubs in Western Europe pursue green chemistry initiatives and circular economy models, while emerging markets in the Middle East and Africa invest in specialty chemical parks to attract foreign technology partnerships. Across Asia-Pacific, robust expansion continues, led by a network of chemical and pharmaceutical enterprises enhancing local synthesis capabilities and securing feedstock supply chains. In this region, strategic alliances between local suppliers and global players facilitate technology transfer and align production with stringent international quality standards. By understanding these regional nuances, companies can tailor distribution strategies, optimize logistics networks, and forge alliances that resonate with local regulatory, economic, and environmental priorities.

Leading Company Profiles and Competitive Strategies

Competitive dynamics are shaped by a diverse cast of established and emerging producers. Aarti Industries Ltd. leverages integrated manufacturing platforms to deliver cost-effective intermediates, while Anhui BBCA Biochemical Co., Ltd. focuses on high-purity grades for pharmaceutical applications. CureChem Group and Emery Oleochemicals LLC emphasize proprietary catalytic processes, and Fengchen Group Co., Ltd. along with Haozhi Biological Technology Co., Ltd. invest heavily in continuous manufacturing. Hubei Hongxin Chemical Co., Ltd. and Jiangsu Euticals Co., Ltd. have built strong reputations in peptide synthesis intermediates, whereas Lonza Group Ltd. combines global reach with stringent regulatory expertise. Ningbo Inno Pharmchem Co., Ltd. and Shanghai Time Chemicals Co., Ltd. prioritize rapid innovation cycles, and Sigma-Aldrich’s position within Merck KGaA underscores its quality leadership. Suzhou Anda Pharmaceutical Co., Ltd., Wacker Chemie AG, and Zhejiang Hisun Chemical Co., Ltd. further enrich the competitive field with specialized derivative portfolios and robust R&D collaborations. Together, these companies drive advancement through strategic partnerships, process innovation, and targeted capacity investments.

Actionable Recommendations for Industry Leaders

To thrive in this evolving environment, industry leaders should adopt a multifaceted approach. First, diversifying synthesis routes-incorporating direct synthesis alongside catalytic hydrogenation-can reduce reliance on tariff-affected imports and enhance margin stability. Second, investing in high-purity production lines and continuous flow reactors will meet stringent regulatory demands and support premium pricing. Third, forming strategic alliances with contract research organizations and biotechnology firms can accelerate access to emerging applications in clinical trials and novel peptide therapeutics. Fourth, leveraging data-driven analytics to monitor feedstock price fluctuations and tariff developments enables proactive sourcing decisions. Fifth, implementing robust quality management systems ensures compliance with global pharmacopoeia standards, safeguarding market access across regions. Finally, exploring circular economy partnerships for waste valorization can strengthen sustainability credentials and unlock cost savings. By executing these recommendations, organizations can position themselves at the forefront of innovation, resilience, and regulatory excellence.

Conclusion Highlighting Strategic Imperatives

D Alpha Parahydroxy Phenylglycine and its derivatives occupy a pivotal niche in modern pharmaceutical and specialty chemical synthesis. The interplay of technological innovation, shifting trade policies, and regional growth patterns demands strategic foresight and operational agility. Detailed segmentation insights reveal clear pathways for differentiation, while regional analysis highlights opportunities and challenges unique to the Americas, Europe/Middle East/Africa, and Asia-Pacific markets. Competitive profiling underscores the importance of process innovation and collaborative ventures. Moving forward, leaders who prioritize diversified synthesis portfolios, invest in high-purity capabilities, and harness advanced analytics for supply chain resilience will secure a sustainable competitive edge. Embracing green chemistry principles and circular economy partnerships will further reinforce market positioning and regulatory compliance, ensuring readiness for evolving industry demands.

Market Segmentation & Coverage

This research report categorizes the D Alpha Parahydroxy Phenylglycine & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Acid
  • Ethyl Ester Hydrochloride
  • Hydrochloride
  • Sodium Salt
  • Chemical Synthesis
    • Asymmetrical Catalysis
    • Peptide Synthesis
  • Pharmaceutical Intermediaries
    • Antibiotics
    • Antidepressants
    • Antihypertensive Agents
  • Research & Development
    • Clinical Trials
    • Laboratory Experiments
  • Chemical Industry
    • Chemical Manufacturing Companies
    • Specialty Chemicals
  • Healthcare Sector
    • Biotechnology Companies
    • Contract Research Organizations
  • Pharmaceutical Industry
    • Drug Manufacturing Firms
    • R&D Institutes
  • Catalytic Hydrogeneration
  • Direct Synthesis
  • Esterification Process
    • Acid-Catalyzed Process
    • Base-Catalyzed Process
  • High Purity (95% - 99%)
  • Low Purity (Below 95%)
  • Ultra-High Purity (99% and Above)
  • Crystalline
  • Liquid
  • Powder

This research report categorizes the D Alpha Parahydroxy Phenylglycine & Derivatives Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the D Alpha Parahydroxy Phenylglycine & Derivatives Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aarti Industries Ltd.
  • Anhui BBCA Biochemical Co., Ltd.
  • CureChem Group
  • Emery Oleochemicals LLC
  • Fengchen Group Co., Ltd.
  • Haozhi Biological Technology Co., Ltd.
  • Hubei Hongxin Chemical Co., Ltd.
  • Jiangsu Euticals Co., Ltd.
  • Lonza Group Ltd.
  • Ningbo Inno Pharmchem Co., Ltd.
  • Shanghai Time Chemicals Co., Ltd.
  • Sigma-Aldrich (a part of Merck KGaA)
  • Suzhou Anda Pharmaceutical Co., Ltd.
  • Wacker Chemie AG
  • Zhejiang Hisun Chemical Co., Ltd.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by Product Type
8.1. Introduction
8.2. Acid
8.3. Ethyl Ester Hydrochloride
8.4. Hydrochloride
8.5. Sodium Salt
9. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by Application
9.1. Introduction
9.2. Chemical Synthesis
9.2.1. Asymmetrical Catalysis
9.2.2. Peptide Synthesis
9.3. Pharmaceutical Intermediaries
9.3.1. Antibiotics
9.3.2. Antidepressants
9.3.3. Antihypertensive Agents
9.4. Research & Development
9.4.1. Clinical Trials
9.4.2. Laboratory Experiments
10. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by End-User Industry
10.1. Introduction
10.2. Chemical Industry
10.2.1. Chemical Manufacturing Companies
10.2.2. Specialty Chemicals
10.3. Healthcare Sector
10.3.1. Biotechnology Companies
10.3.2. Contract Research Organizations
10.4. Pharmaceutical Industry
10.4.1. Drug Manufacturing Firms
10.4.2. R&D Institutes
11. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by Synthesis Process
11.1. Introduction
11.2. Catalytic Hydrogeneration
11.3. Direct Synthesis
11.4. Esterification Process
11.4.1. Acid-Catalyzed Process
11.4.2. Base-Catalyzed Process
12. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by Purity Level
12.1. Introduction
12.2. High Purity (95% - 99%)
12.3. Low Purity (Below 95%)
12.4. Ultra-High Purity (99% and Above)
13. D Alpha Parahydroxy Phenylglycine & Derivatives Market, by Form
13.1. Introduction
13.2. Crystalline
13.3. Liquid
13.4. Powder
14. Americas D Alpha Parahydroxy Phenylglycine & Derivatives Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific D Alpha Parahydroxy Phenylglycine & Derivatives Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa D Alpha Parahydroxy Phenylglycine & Derivatives Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Aarti Industries Ltd.
17.3.2. Anhui BBCA Biochemical Co., Ltd.
17.3.3. CureChem Group
17.3.4. Emery Oleochemicals LLC
17.3.5. Fengchen Group Co., Ltd.
17.3.6. Haozhi Biological Technology Co., Ltd.
17.3.7. Hubei Hongxin Chemical Co., Ltd.
17.3.8. Jiangsu Euticals Co., Ltd.
17.3.9. Lonza Group Ltd.
17.3.10. Ningbo Inno Pharmchem Co., Ltd.
17.3.11. Shanghai Time Chemicals Co., Ltd.
17.3.12. Sigma-Aldrich (a part of Merck KGaA)
17.3.13. Suzhou Anda Pharmaceutical Co., Ltd.
17.3.14. Wacker Chemie AG
17.3.15. Zhejiang Hisun Chemical Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET MULTI-CURRENCY
FIGURE 2. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET MULTI-LANGUAGE
FIGURE 3. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ETHYL ESTER HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SODIUM SALT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ASYMMETRICAL CATALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PEPTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY LABORATORY EXPERIMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL MANUFACTURING COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SPECIALTY CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY DRUG MANUFACTURING FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY R&D INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CATALYTIC HYDROGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY DIRECT SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ACID-CATALYZED PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY BASE-CATALYZED PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HIGH PURITY (95% - 99%), BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY LOW PURITY (BELOW 95%), BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ULTRA-HIGH PURITY (99% AND ABOVE), BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CRYSTALLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 93. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 96. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 97. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 98. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 99. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 100. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 101. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 102. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 103. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 104. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 105. CANADA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 111. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 113. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 114. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 118. MEXICO D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 160. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 163. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 164. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 165. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 166. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 167. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 168. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 169. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 170. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 171. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 172. CHINA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 173. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 176. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 177. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 179. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 180. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 181. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 182. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 183. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 184. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 185. INDIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 199. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 202. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 203. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 204. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 205. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 206. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 207. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 208. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 209. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 210. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 211. JAPAN D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY SYNTHESIS PROCESS, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY ESTERIFICATION PROCESS, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PURITY LEVEL, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL INTERMEDIARIES, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA D ALPHA PARAHYDROXY PHENYLGLYCINE & DERIVATIVES MARKET SIZE, BY CHEMICAL INDUSTRY, 2018-2030 (USD MILLION)
TABLE 258. SOUT

Companies Mentioned

  • Aarti Industries Ltd.
  • Anhui BBCA Biochemical Co., Ltd.
  • CureChem Group
  • Emery Oleochemicals LLC
  • Fengchen Group Co., Ltd.
  • Haozhi Biological Technology Co., Ltd.
  • Hubei Hongxin Chemical Co., Ltd.
  • Jiangsu Euticals Co., Ltd.
  • Lonza Group Ltd.
  • Ningbo Inno Pharmchem Co., Ltd.
  • Shanghai Time Chemicals Co., Ltd.
  • Sigma-Aldrich (a part of Merck KGaA)
  • Suzhou Anda Pharmaceutical Co., Ltd.
  • Wacker Chemie AG
  • Zhejiang Hisun Chemical Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Game IP Derivatives Market by Types (Apparel & Accessories, Sequal Video Games, Stationery), Platform (Console Games, Cross-Platform Games, Mobile Games), Genre - Global Forecast 2025-2030 - Product Image

Game IP Derivatives Market by Types (Apparel & Accessories, Sequal Video Games, Stationery), Platform (Console Games, Cross-Platform Games, Mobile Games), Genre - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Derivatives & Commodities Brokerage Market Report 2025 - Product Image

Derivatives & Commodities Brokerage Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Derivatives Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Derivatives Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Oxetane Derivatives Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Oxetane Derivatives Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 75 Pages
  • Global
From
2025 Dealer Broker Services for Derivatives Contracts Global Market Size & Growth Report with Updated Recession Risk Forecasts by Country - Product Image

2025 Dealer Broker Services for Derivatives Contracts Global Market Size & Growth Report with Updated Recession Risk Forecasts by Country

  • Report
  • 45 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.